Nurix Therapeutics Inc [NRIX]
Pivot-данные
Статистика pivot
| Метрика | Среднее | Медиана | Ст. откл. |
|---|---|---|---|
| Рост % | 16.46% | 16.46% | 0.10% |
| Падение % | -17.57% | -17.57% | 0.00% |
| Длительность | 9.0d | 10d | 1.7d |
| Всего найдено pivot | 4 |
| Фазы роста/падения | 3 (2 Рост / 1 Падение) |
| Последний pivot | Top @ $17.04 на 2026-06-15 |
| Изменение с последнего pivot | $0.00 (0.00%) |
Прогноз следующего pivot Последняя: $17.04
| Ожидаемый следующий тип | Bottom |
| Прогноз цены (средн.) | $14.05 |
| Прогноз цены (медиана) | $14.05 |
| Прогноз диапазона цены (~68%) | $14.05 - $14.05 |
| Изменение к средней цели | $-2.99 (-17.57%) |
| Прогноз даты (средн.) | 2026-06-24 |
| Прогноз диапазона дат (~68%) | 2026-06-22 - 2026-06-25 |
| Основа | Based on 1 historical losses (Avg: -17.57%, Median: -17.57%, StdDev of Abs: 0.00%) and duration (Avg: 9.0 days, StdDev: 1.7 days) |
| Примечание | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Modest rise for Nurix Therapeutics Inc.
Nurix Therapeutics Inc (NRIX) stock price gained some ground on Monday after the stock rose $0.0900 (0.53%) from the previous session on below-average volume. The stock slightly underperformed the market, lagging slightly behind the NASDAQ's 3.07% rise. Yesterday's trading volume was 2.68M shares, worth about $45.70M. This represents 118 926 shares more than the day before. Volume was below the 10-day average of 4.33M shares.
Nurix Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above both moving averages, but the short-term average remains below the long-term average; upward momentum is present but not yet fully confirmed. Market in Equilibrium: A state of indecision prevails across all timeframes, with signals mixed in the short- (23.3%), medium- (23.3%), and long-term (23.3%) horizons. This balance between forces suggests a period of consolidation and the absence of a clear directional catalyst.
Nurix Therapeutics Inc Support & Resistance Levels
The stock is trading above the closest support level at $17.00. approximately $0.0400 (0.23%) away. This suggests it is currently acting as a floor, consolidating near support.The sup dis das support s117 -
Nurix Therapeutics Inc Evaluation
- Короткий оценка: 1.22
- Средний оценка: 3.09
- Длинный оценка: 2.92